Repare Therapeutics Inc. Quarterly Return On Equity in % from Q4 2022 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Repare Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q4 2024.
  • Repare Therapeutics Inc. Return On Equity for the quarter ending December 31, 2024 was -44.5 %, a 11.7% decline year-over-year.
  • Repare Therapeutics Inc. annual Return On Equity for 2024 was -44.5 %, a 11.7% decline from 2023.
  • Repare Therapeutics Inc. annual Return On Equity for 2023 was -39.8 %, a 267% decline from 2022.
  • Repare Therapeutics Inc. annual Return On Equity for 2022 was -10.9 %, a 74.1% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -44.5 -4.65 -11.7% Oct 1, 2024 Dec 31, 2024
Q3 2024 -40.9 -2.26 -5.86% Jul 1, 2024 Sep 30, 2024
Q2 2024 -31.1 -30 -2629% Apr 1, 2024 Jun 30, 2024
Q1 2024 -19.8 -8.8 -79.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -39.8 -29 -267% Oct 1, 2023 Dec 31, 2023
Q3 2023 -38.6 Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.14 Apr 1, 2023 Jun 30, 2023
Q1 2023 -11 Jan 1, 2023 Mar 31, 2023
Q4 2022 -10.9 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.